Abstract
Major epidemiological changes have altered the empiric therapy of patients with bacterial meningitis, a disease with significant morbidity and mortality. We offer recommendations for empiric management decisions and specific antibiotic choices for patients with bacterial meningitis.
MeSH terms
-
Anti-Bacterial Agents / cerebrospinal fluid
-
Anti-Bacterial Agents / therapeutic use*
-
Anti-Inflammatory Agents / therapeutic use
-
Blood-Brain Barrier
-
Drug Resistance, Microbial
-
Drug Therapy, Combination / cerebrospinal fluid
-
Drug Therapy, Combination / therapeutic use
-
Humans
-
Incidence
-
Meningitis, Bacterial / cerebrospinal fluid
-
Meningitis, Bacterial / diagnosis
-
Meningitis, Bacterial / drug therapy*
-
Meningitis, Bacterial / epidemiology
-
Steroids
Substances
-
Anti-Bacterial Agents
-
Anti-Inflammatory Agents
-
Steroids